Orthobunyaviruses: Epidemiology, innate immune escape, and intervention strategies

ABSTRACT Orthobunyaviruses, including La Crosse virus (LACV), Oropouche virus (OROV), Schmallenberg virus (SBV), and Akabane virus (AKAV), pose substantial threats to global public health and livestock industries. This review focuses on the interplay between these viruses and the host immune systems, highlighting key mechanisms of viral entry and immune evasion. The viruses exploit vulnerabilities in host innate immunity, particularly through nonstructural protein NSs, which disrupts type I interferon signaling and transcriptional machinery. Additionally, this review delineates how host restriction factors counteract viral proliferation through compartmentalized defense mechanisms including BST-2 and MxA. The review also discusses antiviral strategies, including vaccines and inhibitors. Hence, this review synthesizes current knowledge on host recognition, immune evasion, and therapies for Orthobunyaviruses infections (focusing on LACV, OROV, AKAV, SBV) to guide targeted antiviral and broad-spectrum countermeasure development against emerging Orthobunyaviruses threats.

• Publication year

  2025

• Venue

  Virulence

• Publication date

  2025-11-11

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1080/21505594.2025.2585624PMID 41217955PMCID 12607300
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A cap-dependent endonuclease inhibitor acts as a potent antiviral agent against La Crosse virus infection

  2025cited by this paper
• Epidemiology, transmission dynamics, treatment strategies, and future perspectives on Oropouche virus.

  2025cited by this paper
• Lysergol exerts potent antiviral activity against the emerging Oropouche virus in vitro.

  2025cited by this paper
• Isolation and identification of an AKAV strain in dairy cattle in China

  2025cited by this paper
• Molecular mechanism of potently neutralizing human monoclonal antibodies against severe fever with thrombocytopenia virus infection

  2025cited by this paper
• Potential therapeutics and vaccines: Current progress and challenges in developing antiviral treatments or vaccines for Oropouche virus.

  2025cited by this paper
• NSm is a critical determinant for bunyavirus transmission between vertebrate and mosquito hosts

  2025cited by this paper
• Rab27a GTPase and its effector Myosin Va are host factors required for efficient Oropouche virus cell egress

  2024cited by this paper
• Viromics-based precision diagnosis of reproductive abnormalities in cows reveals a reassortant Akabane disease virus

  2024cited by this paper
• Identification of NECTIN1 as a novel restriction factor for flavivirus infection

  2024cited by this paper
• Emerging mosquito-borne flaviviruses

  2024cited by this paper
• More than a decade of research on Schmallenberg virus-Knowns and unknowns.

  2024cited by this paper
• Extensive Schmallenberg virus circulation in Germany, 2023

  2024cited by this paper
• N4-Hydroxycytidine/molnupiravir inhibits RNA virus-induced encephalitis by producing less fit mutated viruses

  2024cited by this paper
• Oropouche Virus: An Emerging Orthobunyavirus

  2024cited by this paper
• Promotion of order Bunyavirales to class Bunyaviricetes to accommodate a rapidly increasing number of related polyploviricotine viruses

  2024cited by this paper
• Study of Akabane disease in an Iranian dairy herd: a re-emerging disease

  2024cited by this paper
• Current insights into human pathogenic phenuiviruses and the host immune system

  2024cited by this paper
• Oropouche Virus Exposure in Febrile Patients during Chikungunya Virus Introduction in the State of Amapá, Amazon Region, Brazil

  2024cited by this paper
• Identification of a broadly neutralizing epitope within Gc protein of Akabane virus using newly prepared neutralizing monoclonal antibodies.

  2024cited by this paper
• Current Status of La Crosse Virus in North America and Potential for Future Spread.

  2024cited by this paper
• Oreoch‐1: A broad‐spectrum virus and host‐targeting peptide against animal infections

  2024cited by this paper
• A Scoping Review on the Epidemiology of Orthobunyaviruses in Canada, in the Context of Human, Wildlife, and Domestic Animal Host Species

  2024cited by this paper
• Anti-Schmallenberg Virus Activities of Type I/III Interferons-Induced Mx1 GTPases from Different Mammalian Species

  2023cited by this paper
• Mechanisms of bunyavirus morphogenesis and egress.

  2023cited by this paper
• Structure, function, and evolution of the Orthobunyavirus membrane fusion glycoprotein.

  2023cited by this paper
• The mechanism of genome replication and transcription in bunyaviruses

  2023cited by this paper
• Acridones as promising drug candidates against Oropouche virus

  2023cited by this paper
• The La Crosse virus class II fusion glycoprotein ij loop contributes to infectivity and replication in vitro and in vivo

  2023cited by this paper
• The First Serological Detection and Risk Factors Analysis of Akabane Virus in Egyptian Cattle

  2023cited by this paper
• Two Akabane virus glycoprotein Gc domains induce neutralizing antibodies in mice

  2022cited by this paper
• The Orthobunyavirus Germiston Enters Host Cells from Late Endosomes

  2022cited by this paper
• Vaccine development against Schmallenberg virus: from classical inactivated to modified-live to scaffold particle vaccines

  2022cited by this paper
• Targeted Mutations in the Fusion Peptide Region of La Crosse Virus Attenuate Neuroinvasion and Confer Protection against Encephalitis

  2022cited by this paper
• Oropouche orthobunyavirus infection is mediated by the cellular host factor Lrp1

  2022cited by this paper
• Structural snapshots of La Crosse virus polymerase reveal the mechanisms underlying Peribunyaviridae replication and transcription

  2021cited by this paper
• Neurological disease caused by Oropouche virus in northern Brazil: should it be included in the scope of clinical neurological diseases?

  2021cited by this paper
• La Crosse Virus Disease in the United States, 2003-2019.

  2021cited by this paper
• Evidence of Oropouche Orthobunyavirus Infection, Colombia, 2017

  2021cited by this paper
• Orthobunyaviruses: From Virus Binding to Penetration into Mammalian Host Cells

  2021cited by this paper
• Rottlerin inhibits La Crosse virus-induced encephalitis in mice and blocks release of replicating virus from the Golgi body in neurons

  2021cited by this paper
• Novel Ionophores Active against La Crosse Virus Identified through Rapid Antiviral Screening

  2020cited by this paper
• The Cap-Snatching Mechanism of Bunyaviruses.

  2020cited by this paper
• Elongin C Contributes to RNA Polymerase II Degradation by the Interferon Antagonist NSs of La Crosse Orthobunyavirus

  2020cited by this paper
• A Genome-Wide CRISPR-Cas9 Screen Reveals the Requirement of Host Cell Sulfation for Schmallenberg Virus Infection

  2020cited by this paper
• Orthobunyavirus spike architecture and recognition by neutralizing antibodies

  2019cited by this paper
• The CARD9-Associated C-Type Lectin, Mincle, Recognizes La Crosse Virus (LACV) but Plays a Limited Role in Early Antiviral Responses against LACV

  2019cited by this paper
• Structure of a functional cap-binding domain in Rift Valley fever virus L protein

  2019cited by this paper
• Structure and function of the Toscana virus cap-snatching endonuclease

  2019cited by this paper
• Schmallenberg virus: a systematic international literature review (2011-2019) from an Irish perspective

  2019cited by this paper
• Oropouche Virus–Associated Aseptic Meningoencephalitis, Southeastern Brazil

  2019cited by this paper
• La Crosse virus: a scoping review of the global evidence

  2018cited by this paper
• Bunyavirus requirement for endosomal K+ reveals new roles of cellular ion channels during infection

  2018cited by this paper
• Bunyavirales ribonucleoproteins: the viral replication and transcription machinery

  2018cited by this paper
• Oropouche Fever: A Review

  2018cited by this paper
• ESCRT machinery components are required for Orthobunyavirus particle production in Golgi compartments

  2018cited by this paper
• MicroRNA and cellular targets profiling reveal miR-217 and miR-576-3p as proviral factors during Oropouche infection

  2018cited by this paper
• Sensitivity to BST-2 restriction correlates with Orthobunyavirus host range

  2017cited by this paper
• Oropouche Virus: Clinical, Epidemiological, and Molecular Aspects of a Neglected Orthobunyavirus

  2017cited by this paper
• Lymphocytes have a role in protection, but not in pathogenesis, during La Crosse Virus infection in mice

  2017cited by this paper
• A large-scale serological survey of Akabane virus infection in cattle, yak, sheep and goats in China.

  2017cited by this paper
• Heparan Sulfate Proteoglycan Is an Important Attachment Factor for Cell Entry of Akabane and Schmallenberg Viruses

  2017cited by this paper
• Bovine Arboviruses in Culicoides Biting Midges and Sentinel Cattle in Southern Japan from 2003 to 2013.

  2016cited by this paper
• Akabane virus nonstructural protein NSm regulates viral growth and pathogenicity in a mouse model

  2016cited by this paper
• Oropouche Virus Infection and Pathogenesis Are Restricted by MAVS, IRF-3, IRF-7, and Type I Interferon Signaling Pathways in Nonmyeloid Cells

  2015cited by this paper
• Genetic analysis of members of the species Oropouche virus and identification of a novel M segment sequence

  2015cited by this paper
• Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever

  2015cited by this paper
• Interferon-Regulatory Factor 5-Dependent Signaling Restricts Orthobunyavirus Dissemination to the Central Nervous System

  2015cited by this paper
• Modulation of Potassium Channels Inhibits Bunyavirus Infection*

  2015cited by this paper
• Transcriptome analysis reveals the host response to Schmallenberg virus in bovine cells and antagonistic effects of the NSs protein

  2015cited by this paper
• Capillaries in the olfactory bulb but not the cortex are highly susceptible to virus-induced vascular leak and promote viral neuroinvasion

  2015cited by this paper
• Viral RNA Intermediates as Targets for Detection and Discovery of Novel and Emerging Mosquito-Borne Viruses

  2015cited by this paper
• Age-Dependent Myeloid Dendritic Cell Responses Mediate Resistance to La Crosse Virus-Induced Neurological Disease

  2014cited by this paper
• Orthobunyaviruses: recent genetic and structural insights

  2014cited by this paper
• NSs protein of Schmallenberg virus counteracts the antiviral response of the cell by inhibiting its transcriptional machinery

  2014cited by this paper
• Akabane Virus Utilizes Alternative Endocytic Pathways to Entry into Mammalian Cell Lines

  2014cited by this paper
• Severe Fever with Thrombocytopenia Virus Glycoproteins Are Targeted by Neutralizing Antibodies and Can Use DC-SIGN as a Receptor for pH-Dependent Entry into Human and Animal Cell Lines

  2013cited by this paper
• Expression and purification of the nucleocapsid protein of Schmallenberg virus, and preparation and characterization of a monoclonal antibody against this protein.

  2013cited by this paper
• Orthobunyavirus Entry into Neurons and Other Mammalian Cells Occurs via Clathrin-Mediated Endocytosis and Requires Trafficking into Early Endosomes

  2012cited by this paper
• Novel Orthobunyavirus in Cattle, Europe, 2011

  2012cited by this paper
• Viperin, MTAP44, and Protein Kinase R Contribute to the Interferon-Induced Inhibition of Bunyamwera Orthobunyavirus Replication

  2012cited by this paper
• A serological survey of Akabane virus infection in cattle and sheep in northwest China

  2012cited by this paper
• Polioencephalo- myelitis in a calf due to infection with Schmallenberg virus

  2012cited by this paper
• Ion flux and the function of endosomes and lysosomes: pH is just the start

  2011cited by this paper
• Development of inactivated trivalent vaccine for the teratogenic Aino, Akabane and Chuzan viruses.

  2011cited by this paper
• Recent advances in the molecular and cellular biology of bunyaviruses.

  2011cited by this paper
• Interferon Antagonist NSs of La Crosse Virus Triggers a DNA Damage Response-like Degradation of Transcribing RNA Polymerase II*

  2010cited by this paper
• Bunyamwera virus can repair both insertions and deletions during RNA replication.

  2010cited by this paper
• Serosurveillance for Japanese encephalitis, Akabane, and Aino viruses for Thoroughbred horses in Korea

  2008cited by this paper
• Interferon-inducible antiviral effectors

  2008cited by this paper
• Oropouche virus entry into HeLa cells involves clathrin and requires endosomal acidification☆

  2008cited by this paper
• The unique architecture of Bunyamwera virus factories around the Golgi complex

  2008cited by this paper
• Processing of Genome 5′ Termini as a Strategy of Negative-Strand RNA Viruses to Avoid RIG-I-Dependent Interferon Induction

  2008cited by this paper
• Interferon-induced Mx proteins in antiviral host defense.

  2007cited by this paper
• Bunyavirus mRNA synthesis is coupled to translation to prevent premature transcription termination.

  2007cited by this paper
• Interaction of Bunyamwera Orthobunyavirus NSs Protein with Mediator Protein MED8: a Mechanism for Inhibiting the Interferon Response

  2006cited by this paper
• Requirement of the N-Terminal Region of Orthobunyavirus Nonstructural Protein NSm for Virus Assembly and Morphogenesis

  2006cited by this paper
• Serologic evidence for etiologic role of Akabane virus in epizootic abortion-arthrogryposis-hydranencephaly in cattle in Japan, 1972–1974

  2005cited by this paper
• Inhibition of RNA Polymerase II Phosphorylation by a Viral Interferon Antagonist*

  2004cited by this paper
• Bunyamwera Bunyavirus Nonstructural Protein NSs Counteracts the Induction of Alpha/Beta Interferon

  2002cited by this paper

• No citing papers are available for this paper.